New Drugs for the PCP: What You Need to Know
Keeping up with the many new drugs approved for use each year is a constant challenge. However only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk provides a balanced evaluation of these important novel drugs, and will address efficacy, side effects, cost, and the impact on primary care practice. In addition, we will discuss at length the efficacy and safety of the COVID vaccines available in the U.S. through Emergency Use Authorization.
- Review recently approved drugs will have the largest impact on primary care practice.
- Understand the efficacy, side effects, and cost of important novel drugs in primary care practice.
- Discuss the role of recently approved medications and their place among existing therapies.
- Examine the efficacy and safety of COVID vaccines in order to best counsel your patients.
Gerald W. Smetana, MD
Professor of Medicine
Harvard Medical School
Clinician Educator, Division of General Medicine and Primary Care
Beth Israel Deaconess Medical Center Boston, MA
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Gerald W. Smetana, MD: No relevant financial relationships disclosed.
Martin A. Quan, MD (moderator): No relevant financial relationships disclosed.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
AMA PRA Category 1 Credits™
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pri-Med Institute is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number 040308.
This activity is approved for 1.00 contact hour of continuing education, which includes 1.00 hour of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Instructions for Obtaining Credit
Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 3 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.
- 1.00 AANP Contact Hours
- 1.00 Pharmacology
- 1.00 AANP Pharmacology Contact Hours
- 1.00 MOC
- 1.00 AMA PRA Category 1 Credit™
This course is offered through Pri-Med.
To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!